Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/658
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKusumawardhana, R. Naufal Hilmi-
dc.date.accessioned2023-03-14T08:08:58Z-
dc.date.available2023-03-14T08:08:58Z-
dc.date.issued2023-01-01-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/658-
dc.description.abstractfour-month internship was conducted in PT. Bio Farma Bandung as a study following the Enrichment Program held by i3L. PT. Bio Farma is a state-owned biopharmaceutical company located in Bandung, established with a focus on the research and development of vaccines in Indonesia. As part of the Tetanus Vaccine Production department, the author worked directly on the production facilities, particularly with the fermentors mainly to conduct the sterile hold test (SHT) in the tetanus vaccine production facility. SHT was conducted in order to show and prove that the fermentors are suitable for use and able to maintain a sterile condition throughout the tetanus vaccine production process. The results showed that the facility is able to maintain a sterile environment, with the exception of one inoculum fermentor. Other than the SHT, the author also helped with writing and translating documents related to the tetanus vaccine production.en_US
dc.language.isoenen_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesEP BT023;EP23058-
dc.subjectTetanus vaccineen_US
dc.subjecttetanus toxoiden_US
dc.subjectsterile hold testen_US
dc.subjectcGMPen_US
dc.titleSterile Hold Test (SHT) of the Tetanus Vaccine Production Facility in PT. Bio Farmaen_US
dc.typeWorking Paperen_US
Appears in Collections:BT

Files in This Item:
File Description SizeFormat 
EP BT024_Jonathan Alexander.pdf
  Restricted Access
Full Time1.37 MBAdobe PDFView/Open Request a copy


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.